RE: you17 Mar 2018 10:38
I think we have the opportunity this weekend to take stock and get an emotional breadth. For me there's still residual value and the worst scenario has already been priced in and outlined in the Form of Order hearing.
The Company has not been shy in granting Options at various exercisable prices and various exercisable dates to its MANAGEMENT TEAM whom I have no sympathy for. These are exercisable at various dates up to 29 October 2027. Options granted are exercisable for 10 years and therefore range from 2015 when I think the first lot were granted. The Company has roughly 40m shares under option and a further 95,688,706 shares under warrant. The number of shares under Options or EMI represents 12.4 per cent approx. of the Company's existing ordinary share capital.
The Directors have 23% share ownership currently, Bill Chang is the biggest holder, and YourGene who are sitting on a major loss on their 7p odd share swap are sitting on a major loss with no share sales to date. Basically everyone is under water as they too were expecting many spikes through the last 3 years hence granting Options left right and centre. So the final options were granted for 3,825,000 in October 2016 (hence 29 October 2027 being the last exercisable date) at a price of 10 pence per share. The number of shares under option are as below from March 2016 though this doesn't include the 3.8m above as the recipients not identified.
Stephen Little 14,028,711
Peter Collins 9,160,901
William Denman 2,904,989
Michael Risley 2,669,989
Rachel Shelmerdine 1,070,598
Adam Reynolds 3,892,803
Barry Hextall1 1,000,000
These are exercisable from 10p onward to 20p.